SCHEMBL11265892

SCHEMBL11265892

BNF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14750937 0.72
SCHEMBL846932 0.72
SCHEMBL372757 0.61
SCHEMBL713232 0.61
SCHEMBL1296249 0.58
SCHEMBL20310048 0.55
Ammonia Solution, Strong SCHEMBL17274476 0.55
SCHEMBL16249960 0.50
SCHEMBL18810182 0.50
SCHEMBL7144412 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690380-B2 Antimicrobial guanidinium and thiouronium functionalized polymers CORAL BAY II, LLC (US) 2023-07-04 US disclosed
US-10246634-B2 Quantum dot having polymeric outer layer, photosensitive compositions including the same, and quantum dot polymer composite pattern produced therefrom SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-04-02 US disclosed
US-10040879-B2 Fluoro-alcohol additives for orientation control of block copolymers INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2018-08-07 US disclosed
US-9999633-B2 Antimicrobial cationic polycarbonates INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2018-06-19 US disclosed
US-9987369-B2 Vitamin functionalized gel-forming block copolymers for biomedical applications INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2018-06-05 US disclosed
US-9982097-B2 Thin film self assembly of topcoat-free silicon-containing diblock copolymers INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2018-05-29 US disclosed
US-9974303-B2 Cationic polymers for antimicrobial applications and delivery of bioactive materials INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2018-05-22 US disclosed
US-20180117162-A1 VITAMIN FUNCTIONALIZED GEL-FORMING BLOCK COPOLYMERS FOR BIOMEDICAL APPLICATIONS INTERNATIONAL BUSINESS MACHINES CORPORATION 2018-05-03 US disclosed
US-20180112033-A1 POLYESTER NANOGEL CORE STAR POLYMERS FOR DELIVERY OF THERAPEUTIC AGENTS INTERNATIONAL BUSINESS MACHINES CORPORATION 2018-04-26 US disclosed
US-9951179-B2 Cyclic carbonate monomers and ring opened polycarbonates therefrom INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2018-04-24 US disclosed
US-20150023940-A1 METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10) BERG PHARMA LLC (US) 2015-01-22 US disclosed
US-20140255430-A1 METHODS AND REAGENTS FOR DETECTION AND TREATMENT OF ESOPHAGEAL METAPLASIA NATIONAL UNIVERSITY OF SINGAPORE (SG) 2014-09-11 US disclosed
US-20140215653-A1 IDENTIFICATION AND USE OF EARLY EMBRYO AND/OR EARLY ENDOSPERM SPECIFIC PROMOTERS FOR GENE EXPRESSION IN MAIZE TARGETED GROWTH, INC. (US) 2014-07-31 US disclosed
US-20140079836-A1 METHODS AND COMPOSITIONS FOR ALTERING HEALTH, WELLBEING, AND LIFESPAN LifeSpan Extension, LLC 2014-03-20 US disclosed
US-20130156795-A1 METHODS FOR INHIBITION OF CELL PROLIFERATION, SYNERGISTIC TRANSCRIPTION MODULES AND USES THEREOF THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2013-06-20 US disclosed
US-20110123986-A1 METHODS FOR THE DIAGNOSIS OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS BERG PHARMA LLC 2011-05-26 US disclosed
US-20110123987-A1 METHODS FOR THE DIAGNOSIS OF ONCOLOGICAL DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS BPGBIO, INC. 2011-05-26 US disclosed
US-20110027247-A1 METHODS FOR TREATMENT OF ONCOLOGICAL DISORDERS USING AN EPIMETABOLIC SHIFTER (COENZYME Q10) BERG LLC 2011-02-03 US disclosed
US-20110020312-A1 METHODS FOR TREATMENT OF METABOLIC DISORDERS USING EPIMETABOLIC SHIFTERS, MULTIDIMENSIONAL INTRACELLULAR MOLECULES, OR ENVIRONMENTAL INFLUENCERS BERG LLC 2011-01-27 US disclosed
US-4366108-A Liquid matrix system based on a mixture of epoxide resin and an amine curing agent for producing fibre-reinforced plastics components CIBA-GEIGY CORPORATION (US) 1982-12-28 US disclosed